Platelet-derived Growth Factor Receptors (PDGFRs) Fusion Genes Involvement in Hematological Malignancies

Overview

Journal Crit Rev Oncol Hematol

Specialty Hematology

Date 2016 Dec 25

PMID 28010895

Citations 18

Authors

Kwaku Appiah-Kubi

Ting Lan

Ying Wang

Hai Qian

Min Wu

Xiaoyuan Yao

Yan Wu

Yongchang Chen

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate oncogenic platelet-derived growth factor receptor(PDGFR) fusion genes involvement in hematological malignancies, the advances in the PDGFR fusion genes diagnosis and development of PDGFR fusions inhibitors.

Methods: Literature search was done using terms "PDGFR and Fusion" or "PDGFR and Myeloid neoplasm" or 'PDGFR and Lymphoid neoplasm' or "PDGFR Fusion Diagnosis" or "PDGFR Fusion Targets" in databases including PubMed, ASCO.org, and Medscape.

Results: Out of the 36 fusions detected, ETV6(TEL)-PDGFRB and FIP1L1-PDGFRA fusions were frequently detected, 33 are as a result of chromosomal translocation, FIP1L1-PDGFRA and EBF1-PDGFRB are the result of chromosomal deletion and CDK5RAP2- PDGFRΑ is the result of chromosomal insertion. Seven of the 34 rare fusions have detectable reciprocals.

Conclusion: RNA aptamers are promising therapeutic target of PDGFRs and diagnostic tools of PDGFRs fusion genes. Also, PDGFRs have variable prospective therapeutic strategies including small molecules, RNA aptamers, and interference therapeutics as well as development of adaptor protein Lnk mimetic drugs.

Citing Articles

Functional and clinical roles of stromal PDGF receptors in tumor biology.

Strell C, Rodriguez-Tomas E, Ostman A Cancer Metastasis Rev. 2024; 43(4):1593-1609.

PMID: 38980580 PMC: 11554757. DOI: 10.1007/s10555-024-10194-7.

Fusion of Platelet Derived Growth Factor Receptor Alpha () With Ubiquitin Specific Peptidase 8 () in a Calcified Chondroid Mesenchymal Neoplasm Harboring t(4;15)(q12;q21) as a Sole Aberration.

Panagopoulos I, Andersen K, Gorunova L, Lobmaier I Cancer Genomics Proteomics. 2024; 21(3):252-259.

PMID: 38670591 PMC: 11059595. DOI: 10.21873/cgp.20444.

The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.

Xu G, Zeng Z, Zhang Z, Zhang X, Wang M, Xiao Q J Cell Mol Med. 2024; 28(3):e18114.

PMID: 38323741 PMC: 10844707. DOI: 10.1111/jcmm.18114.

Myeloid/Lymphoid Neoplasms with Fusion Gene: A Rare Case of Poor Response to Imatinib and Possible Transformation Mechanisms from Myeloid Neoplasms of Bone Marrow to T-Cell Lymphoblastic Lymphoma Invasion in Lymph Nodes.

Gou Y, Tang Y, Liu S, Cheng S, Deng X, Wen Q J Inflamm Res. 2023; 16:5163-5170.

PMID: 38026242 PMC: 10649033. DOI: 10.2147/JIR.S427995.

Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.

Vargas J, Pantouris G Int J Mol Sci. 2023; 24(21).

PMID: 37958963 PMC: 10650716. DOI: 10.3390/ijms242115981.